Nitric oxide prodrug JS-K inhibits ubiquitin E1 and kills tumor cells retaining wild-type p53

Jirouta Kitagaki(National Institutes of Health), Alan O. Perantoni(National Cancer Institute), Nancy H. Colburn(Gene Therapy Laboratory), Larry K. Keefer(Unknown), Joseph E. Saavedra(Genesis Laboratories), Yili Yang(Buchang Pharma (China))
Oncogene
November 3, 2008
Cited by 58


Related Papers